SFX by Ex Libris Inc.

Title:	Static and Dynamic Permeability Assay for Hydrophilic Small Molecules Using a Planar Droplet Interface Bilayer
Source:	Analytical Chemistry [0003-2700] Lee, Yohan yr:2018

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	von Nussbaum, F. "Multiple Attack on Bacteria by the New Antibiotic Teixobactin." Angewandte Chemie (International ed.) 54.23 (2015): 6684-6686.
description	2.	"Researchers at University of Southern Denmark Report New Data on Drug Delivery Systems (Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems)." Biotech week. 263-.
description	3.	Boegh, M. "Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption." European journal of pharmaceutics and biopharmaceutics 87.2 (2014): 227-235.
description	4.	Nisisako, T. "Microfluidic passive permeability assay using nanoliter droplet interface lipid bilayers." Analyst 138.22 (2013): 6793-800.
description	5.	Homma, T. "Dual targeting of cell wall precursors by teixobactin leads to cell lysis." Antimicrobial agents and chemotherapy 60.11 (2016): 6510-6517.
description	6.	Ling, L. "A new antibiotic kills pathogens without detectable resistance." Nature 517.7535 (2015): 455-459.
description	7.	"Data on Biomimetics Discussed by Researchers at Catholic University of Leuven (Drug permeability profiling using cell-free permeation tools: Overview and applications)." Biotech week. 115-.
description	8.	Naicker, T. "APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans." Journal of the American Society of Nephrology 26.11 (2015): 2882-90.
description	9.	Inoue, K. "Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane." Nature Chemical Biology 11.2 (2014): 127-133.
description	10.	Anonymous. "Reasons to be cheerful." Nature 517.7533 (2015): 121-121.
description	11.	Arnaud, Arnaud u. "A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure." European journal of pharmaceutics and biopharmaceutics 87.2 (2014): 290-298.
description	12.	Stephanopoulos, N. "Choosing an effective protein bioconjugation strategy." Nature chemical biology 7.12 (2011): 876-884.
description	13.	Wright, G. "Antibiotics: An irresistible newcomer." Nature 517.7535 (2015): 442-444.
description	14.	Lewis, K. "Platforms for antibiotic discovery." Nature reviews. Drug discovery 12.5 (2013): 371-387.
description	15.	Zipperer, A. "Human commensals producing a novel antibiotic impair pathogen colonization." Nature 535.7613 (2016): 511-516.
description	16.	Kaeberlein, T. "Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment." Science 296.5570 (2002): 1127-1129.
description	17.	Rabuka, D. "Site-specific chemical protein conjugation using genetically encoded aldehyde tags." Nature protocols 7.6 (2012): 1052-1067.
description	18.	Nichols, D. "Use of Ichip for High-Throughput In Situ Cultivation of "Uncultivable" Microbial Species." Applied and environmental microbiology 76.8 (2010): 2445-2450.
description	19.	Dhara, S. "Solution-Phase Synthesis of the Macrocyclic Core of Teixobactin." European journal of organic chemistry 2016.25 (2016): 4289-4293.
description	20.	Butani, S. "Combating Tuberculosis Infection: A Forbidding Challenge." Indian Journal of Pharmaceutical Sciences 78.1 (2016): 8-16.